Prediction of malignant middle cerebral artery infarction by plasma MMP-9 and hsCRP level
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.1008-6706.2010.10.004
- Key Word:
- 梗塞,大脑中动脉;基质金属蛋白酶9;C反应蛋白质;体层摄影术,X线计算机;Infarction,middle cerebral artery;Matrix metalloproteinase 9;C-reactive protein;Tomography,x-ray computed
Abstract： Objective To evaluate the predicting value of the marker of endothelial injury: plasma matrix metalloproteinase-9( MMP-9) and high sensitivity C-reactive protein( hsCRP) level on the progression of acute anterior circulating territory infarction progressing to malignant middle cerebral artery infarction (m-MCAI). Methods 90 patients with acute anterior circulating territory infarction, in which 46 patients progressed to m-MCAI, were collected and sampled consecutively. The plasma MMP-9 and hsCRP of all patients were determined by ELISA and immunotur-bidimetry,respectively,at admission. And the clinical characters and cranial CT features of the patients were analyzed. Results At admission,the plasma MMP-9 level in the patients with m-MCAI(242.0 ±58.0)ng/ml was significantly higher than that in the patients with non m-MCAI( 169.0 ± 50.0) ng/ml( P < 0. 01) ,the plasma hsCRP level in the patients with m-MCAI(6.25 ±1.2) ng/ml was significantly higher than that in the patients with non m-MCAI( 1.55 ± 0.9) mg/ml( P <0. 01).Conclusion The increased level of plasma MMP-9 and hsCRP could be predictors for the m-MCAI proceeding.
- [1]Hongxin Wang,Yuanwu MEI.The effect of hyperglycemia on blood brain barrier of rats with focal cerebral ischemia/reperfusion injury[J].2005,(5).
- [2]Sobesky J,Heiss WD,Graf R,etc.Prediction of malignant course in MCA infarction by PET and microdialysis.[J].2003,34(9).
- [3]Mabuchi T,Koziol JA,del Zoppo GJ,etc.Focal cerebral ischemia induces active proteases that degrade microvascular matrix.[J].2004,35(4).
- [4]Vukasovic I,Petrovcic M,Topic E,etc.Matrix metalloproteinases and their inhibitors in different acute stroke subtypes.[J].2006,44(4).
- [5]W, Hacke,S, Schwab,M, Horn,etc.'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.[J].1996,53(4).
- [6]Molina CA,Lo EH,Rosell A,etc.Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.[J].2006,37(6).
- [7]Kloska SP,Nam E,Ringelstein EB,etc.Accuracy of perfusion-CT in predicting malignant middle cerebral artery brain infarction.[J].2008,255(6).
- [8]Bassuk SS,Rifai N,Ridker PM.High-sensitivity C-reactive protein: clinical importance.[J].2004,29(8).
- [9]Mark A, Reynolds,Howard J, Kirchick,Jeffrey R, Dahlen,etc.Early biomarkers of stroke.[J].2003,49(10).
- [10]Blanco M,Castellanos M,Moro MA,etc.The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.[J].2005,36(9).
- [11]D. Moulin,R. Lo,J. Chiang,etc.Prognosis in Middle Cerebral Artery Occlusion[J].1985,16(2).
- [12]Jeffrey M, Gidday,Yvan G, Gasche,Jean-C, Copin,etc.Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.[J].2005,289(2).
- [13]Vasan RS.Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.[J].2006,17(1).
- [14]Huang FengPing,Keep RichardF,Xi Guohua,etc.Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products.[J].2002,96(2).
- [15]Christou I,Kasner SE,Berrouschot J,etc.Predictors of fatal brain edema in massive hemispheric ischemic stroke.[J].2001,32(9).
- [16]Nikolaj, Eldrup,Marie-Louise Moes, Gr?nholdt,Henrik, Sillesen,etc.Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis.[J].2006,114(17).